What is Ginkgo Bioworks's restricted cash?

Ginkgo Bioworks (DNA) reported restricted cash of $6.88M in Q1 2026.

How has Ginkgo Bioworks's restricted cash changed year-over-year?

Ginkgo Bioworks's restricted cash decreased by 13.3% year-over-year, from $7.94M to $6.88M.

What is the long-term trend for Ginkgo Bioworks's restricted cash?

Over 5 years (2020 to 2025), Ginkgo Bioworks's restricted cash has grown at a 54.8% compound annual growth rate (CAGR), from $5.08M to $45.17M.

What does restricted cash mean?

Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.

Ginkgo Bioworks DNA Restricted Cash

Restricted Cash at other companies

AbCellera Biologics Inc.ABCL

$25M0.0%

AzentaAZTA

$2.41M—

RegenxbioRGNX

$2.03M0.0%

Sana BiotechnologySANA

$4.2M0.0%

Thermo Fisher ScientificTMO

——

Charles River LaboratoriesCRL

——

Other financials

Income statement

See full

Revenue$19.5M-49.1%

Gross profit$16.4M-52.0%

Operating income-$71.4M+11.9%

Net income-$82.6M+9.2%

EPS (diluted)-$1.42+27.6%

Balance sheet

See full

Cash & equivalents$188.7M-46.9%

Total debt$410.7M-5.5%

Total equity$443.2M-31.6%

Total assets$1.0B-20.1%

Cash flow

See full

Operating cash flow-$46.7M+9.4%

CapEx$1.9M-74.6%

Free cash flow-$48.6M+17.8%

Valuation

See full

Market cap$625.16M+24.6%

Enterprise value$847.19M+45.9%

P/S4.4×+2.2×

Profitability

See full

Operating margin-210.7%+7.6pp

Net margin-215.4%+8.3pp

FCF margin-119%-21.2pp

Returns & leverage

See full

Return on equity-55.8%-1.8pp

Debt / equity0.9×+0.3×

Current ratio5.2×+0.3×

Where this comes from

Reported directly by Ginkgo Bioworks in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashCurrent.

The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ginkgo Bioworks's restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ginkgo Bioworks's restricted cash?: Ginkgo Bioworks (DNA) reported restricted cash of $6.88M in Q1 2026.
How has Ginkgo Bioworks's restricted cash changed year-over-year?: Ginkgo Bioworks's restricted cash decreased by 13.3% year-over-year, from $7.94M to $6.88M.
What is the long-term trend for Ginkgo Bioworks's restricted cash?: Over 5 years (2020 to 2025), Ginkgo Bioworks's restricted cash has grown at a 54.8% compound annual growth rate (CAGR), from $5.08M to $45.17M.
What does restricted cash mean?: Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.